Applicant, as named in the Orange Book

Ferring Pharms Inc

Next listed expiry: Clenpiq on 27 Jan 2038. 1 products with live protection, 2 without.

Products with listed protection

Drug	Ingredient	Earliest generic entry	Basis
Clenpiq NDA 209589 citric acid; magnesium oxide; sodium picosulfate	citric acid; magnesium oxide; sodium picosulfate	27 Jan 2038 patent	patent

No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.

Products without listed protection (2)

Drug	Ingredient	Earliest generic entry	Basis
Cervidil NDA 020411 dinoprostone	dinoprostone	open now no listed protection	no listed protection
Ddavp NDA 019955 · 2 strengths desmopressin acetate	desmopressin acetate	open now no listed protection	no listed protection